TABLE OF CONTENTS

Volume 13, Issue 5 (May 2006)

Top

Editorial

Adventitious Mutations in Clinical Grade Vectors: An Issue to Consider?

David A. Williams and Timothy P. Cripe

Mol Ther 13: 831-832; doi:10.1016/j.ymthe.2005.03.040

Top

Inside this Month

Inside this Month

Mol Ther 13: 833; doi:10.1016/j.ymthe.2006.03.016

Top

Research Update

Research Updated

Mol Ther 13: 834; doi:10.1016/j.ymthe.2005.03.041

Top

Commentary

Gene Therapy for Diabetic Cardiomyopathy: A New Approach for a Difficult Problem

Mol Ther 13: 835-838; doi:10.1016/j.ymthe.2006.03.013

Top

Review Article

Gene Therapy for Lysosomal Storage Diseases

Mark S. Sands and Beverly L. Davidson

Mol Ther 13: 839-849; doi:10.1016/j.ymthe.2006.01.006

Dendritic Cell-Based Tumor Vaccines and Antigen Presentation Attenuators

Kevin Evel-Kabler and Si-Yi Chen

Mol Ther 13: 850-858; doi:10.1016/j.ymthe.2006.02.009

Top

Original Articles

Widespread Correction of Lysosomal Storage in the Mucopolysaccharidosis Type VII Mouse Brain with a Herpes Simplex Virus Type 1 Vector Expressing beta-Glucuronidase

Bradford K. Berges, Srikanth Yellayi, Brian A. Karolewski, Richard R. Miselis, John H. Wolfe and Nigel W. Fraser

Mol Ther 13: 859-869; doi:10.1016/j.ymthe.2005.12.017

Intranasal Administration of the Growth-Compromised HSV-2 Vector DeltaRR Prevents Kainate-Induced Seizures and Neuronal Loss in Rats and Mice

Jennifer M. Laing, Michael D. Gober, Erin K. Golembewski, Scott M. Thompson, Kymberly A. Gyure, Paul J. Yarowsky and Laure Aurelian

Mol Ther 13: 870-881; doi:10.1016/j.ymthe.2005.12.013

A Mutant Type 2 Herpes Simplex Virus Deleted for the Protein Kinase Domain of the ICP10 Gene Is a Potent Oncolytic Virus

Xinping Fu, Lihua Tao, Rong Cai, Jonathan Prigge and Xiaoliu Zhang

Mol Ther 13: 882-890; doi:10.1016/j.ymthe.2006.02.007

Oncolytic Viruses Derived from the bold gamma34.5-Deleted Herpes Simplex Virus Recombinant R3616 Encode a Truncated UL3 Protein

Megan J. Dambach, Jordan Trecki, Natalia Martin and Nancy S. Markovitz

Mol Ther 13: 891-898; doi:10.1016/j.ymthe.2006.02.006

Targeted Therapy of DNA Tumor Virus-Associated Cancers Using Virus-Activated Transcription Factors

Mi Jung Lim, Sang-Hyun Min, Jae-Jung Lee, Il Chul Kim, Ji Tae Kim, Dong Chul Lee, Nam-Soon Kim, Sangkyun Jeong, Mi Na Kim, Kwang Dong Kim, Jong-Seok Lim, Sang Bae Han, Hwan Mook Kim, Dae Seog Heo and Young Il Yeom

Mol Ther 13: 899-909; doi:10.1016/j.ymthe.2005.11.023

Blockade of TNF-alpha Decreases Both Inflammation and Efficacy of Intrapulmonary Ad.IFNbeta Immunotherapy in an Orthotopic Model of Bronchogenic Lung Cancer

Michael J. Wilderman, Samuel Kim, Collin T. Gillespie, Jing Sun, Veena Kapoor, Anil Vachani, Daniel H. Sterman, Larry R. Kaiser and Steven M. Albelda

Mol Ther 13: 910-917; doi:10.1016/j.ymthe.2005.12.012

Immune Gene–Viral Therapy with Triplex Efficacy Mediated by Oncolytic Adenovirus Carrying an Interferon-bold gamma Gene Yields Efficient Antitumor Activity in Immunodeficient and Immunocompetent Mice

Changqing Su, Linhui Peng, Jonathan Sham, Xinghua Wang, Qi Zhang, Daniel Chua, Chen Liu, Zhenfu Cui, Huibin Xue, Hongping Wu, Qin Yang, Baihe Zhang, Xinyuan Liu, Mengchao Wu and Qijun Qian

Mol Ther 13: 918-927; doi:10.1016/j.ymthe.2005.12.011

Selective Targeting of Checkpoint Kinase 1 in Tumor Cells with a Novel Potent Oncolytic Adenovirus

Qinglei Gao, Jianfeng Zhou, Xiaoyuan Huang, Gang Chen, Fei Ye, Yunping Lu, Kanyan Li, Liang Zhuang, Mei Huang, Gang Xu, Shxuan Wang and Ding Ma

Mol Ther 13: 928-937; doi:10.1016/j.ymthe.2005.12.009

Selective Intratumoral Amplification of an Antiangiogenic Vector by an Oncolytic Virus Produces Enhanced Antivascular and Anti-tumor Efficacy

Stephen H. Thorne, Betty Y.Y. Tam, David H. Kirn, Christopher H. Contag and Calvin J. Kuo

Mol Ther 13: 938-946; doi:10.1016/j.ymthe.2005.12.010

Role of SCC-S2 in Experimental Metastasis and Modulation of VEGFR-2, MMP-1, and MMP-9 Expression

Chuanbo Zhang, Debyani Chakravarty, Isamu Sakabe, Rajshree R. Mewani, Howard E. Boudreau, Deepak Kumar, Imran Ahmad and Usha N. Kasid

Mol Ther 13: 947-955; doi:10.1016/j.ymthe.2005.11.020

AAV Serotype 8-Mediated Gene Delivery of a Soluble VEGF Receptor to the CNS for the Treatment of Glioblastoma

Thomas C. Harding, Alshad S. Lalani, Byron N. Roberts, Satya Yendluri, Bo Luan, Kathryn E. Koprivnikar, Melissa Gonzalez-Edick, Guang Huan-Tu, Randy Musterer, Melinda J. VanRoey, Tomoko Ozawa, Richard A. LeCouter, Dennis Deen, Peter J. Dickinson and Karin Jooss

Mol Ther 13: 956-966; doi:10.1016/j.ymthe.2006.02.004

Long-term Doxycycline-regulated Transgene Expression in the Retina of Nonhuman Primates Following Subretinal Injection of Recombinant AAV Vectors

Knut Stieger, Guylène Le Meur, Françoise Lasne, Michel Weber, Jack-Yves Deschamps, Delphine Nivard, Alexandra Mendes-Madeira, Nathalie Provost, Laurent Martin, Philippe Moullier and Fabienne Rolling

Mol Ther 13: 967-975; doi:10.1016/j.ymthe.2005.12.001

Transduction of Myogenic Cells by Retargeted Dual High-Capacity Hybrid Viral Vectors: Robust Dystrophin Synthesis in Duchenne Muscular Dystrophy Muscle Cells

Manuel A. F. V. Gonçalves, Maarten Holkers, Christophe Cudré-Mauroux, Gijsbert P. van Nierop, Shoshan Knaän-Shanzer, Ietje van der Velde, Dinko Valerio and Antoine A.F. de Vries

Mol Ther 13: 976-986; doi:10.1016/j.ymthe.2005.11.018

Mechanical and Metabolic Rescue in a Type II Diabetes Model of Cardiomyopathy by Targeted Gene Transfer

Susumu Sakata, Djamel Lebeche, Yuri Sakata, Naoya Sakata, Elie R. Chemaly, Li Fan Liang, Prabhu Padmanabhan, Noboru Konishi, Miyako Takaki, Federica del Monte and Roger J. Hajjar

Mol Ther 13: 987-996; doi:10.1016/j.ymthe.2006.01.002

Genetic Targeting of Adenovirus Vectors Using a Reovirus sigma1-Based Attachment Protein

Frederik H.E. Schagen, Felix M. Wensveen, Jan E. Carette, Terence S. Dermody, Winald R. Gerritsen and Victor W. van Beusechem

Mol Ther 13: 997-1005; doi:10.1016/j.ymthe.2005.11.019

Sustained FVIII Expression and Phenotypic Correction of Hemophilia A in Neonatal Mice Using an Endothelial-Targeted Sleeping Beauty Transposon

Li Liu, Cathryn Mah and Bradley S. Fletcher

Mol Ther 13: 1006-1015; doi:10.1016/j.ymthe.2005.11.021

In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMTP140K-Transduced Human G-CSF-Mobilized Peripheral Blood Cells

Shanbao Cai, Jennifer R. Hartwell, Ryan J. Cooper, Beth E. Juliar, Emi Kreklau, Rafat Abonour, W. Scott Goebel and Karen E. Pollok

Mol Ther 13: 1016-1026; doi:10.1016/j.ymthe.2005.11.017

Extra navigation

.

naturejobs

ADVERTISEMENT